During the past decade, Research Institute for Biological Safety Problems Committee of Science of the Ministry of Education and Science of the Republic of Kazakhstan conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Research Institute for Biological Safety Problems Committee of Science of the Ministry of Education and Science of the Republic of Kazakhstan" #1 collaborator was "City Multidisciplinary Hospital of the Health Department of the Akimat of Zhambyl Region" with 1 trials as a collaborator, "City polyclinic No. 4 of the UZO of Almaty" with 1 trials as a collaborator, "Clinic of the International Institute of Postgraduate Education" with 1 trials as a collaborator and "National Scientific Center for Phthisiopulmonology of the Republic of Kazakhstan" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Research Institute for Biological Safety Problems Committee of Science of the Ministry of Education and Science of the Republic of Kazakhstan" are "Covid19" (3 trials), "SARS-CoV Infection" (3 trials) and "Vaccine Adverse Reaction" (3 trials). Many other conditions were trialed in "Research Institute for Biological Safety Problems Committee of Science of the Ministry of Education and Science of the Republic of Kazakhstan" in a lesser frequency.

Most popular intervention types in "Research Institute for Biological Safety Problems Committee of Science of the Ministry of Education and Science of the Republic of Kazakhstan" are "Biological" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "QazCoVac-P -COVID-19 Subunit Vaccine" (1 trials), "QazCovid-in® - COVID-19 inactivated vaccine" (1 trials) and "QazCovid-in®-vaccine against COVID-19" (1 trials). Other intervention names were less common.

The vast majority of trials in "Research Institute for Biological Safety Problems Committee of Science of the Ministry of Education and Science of the Republic of Kazakhstan" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Research Institute for Biological Safety Problems Committee of Science of the Ministry of Education and Science of the Republic of Kazakhstan". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Research Institute for Biological Safety Problems Committee of Science of the Ministry of Education and Science of the Republic of Kazakhstan, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Research Institute for Biological Safety Problems Committee of Science of the Ministry of Education and Science of the Republic of Kazakhstan, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".